Page last updated: 2024-10-27

flumazenil and Enterically-Transmitted Non-A, Non-B Hepatitis

flumazenil has been researched along with Enterically-Transmitted Non-A, Non-B Hepatitis in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Halánová, M1
Veseliny, E1
Kalinová, Z1
Jarčuška, P1
Janičko, M1
Urbančíková, I1
Pella, D1
Dražilová, S1
Babinská, I1

Other Studies

1 other study available for flumazenil and Enterically-Transmitted Non-A, Non-B Hepatitis

ArticleYear
Seroprevalence of Hepatitis E Virus in Roma Settlements: A Comparison with the General Population in Slovakia.
    International journal of environmental research and public health, 2018, 05-03, Volume: 15, Issue:5

    Topics: Adult; Antibodies, Viral; Cross-Sectional Studies; Female; Hepatitis E; Hepatitis E virus; Humans; M

2018